Service profile
TG Therapeutics
Develops novel treatments for B-cell malignancies and autoimmune diseases, with marketed products and pipeline candidates targeting chronic lymphocytic leukemia, non-Hodgkin lymphoma, and multiple sclerosis through protein kinase inhibition and antibody therapies.
About
What TG Therapeutics is
Develops novel treatments for B-cell malignancies and autoimmune diseases, with marketed products and pipeline candidates targeting chronic lymphocytic leukemia, non-Hodgkin lymphoma, and multiple sclerosis through protein kinase inhibition and antibody therapies.
losclouds keeps public details for this profile. There are no catalog offerings to compare yet.
EnterpriseHealthcare
At a glance
| Fact | Value |
|---|---|
| Official site | https://tgtherapeutics.com |
| Status coverage | Public status page |
| Founded | 1993 |
| Headquarters | New York, New York, United States |
| Categories | Enterprise, Healthcare |
Loading offerings...